Why the US Leaving the World Health Organization is Short-Sighted
On 22 January 2026, the United States announced that it was formally withdrawing from the World Health Organization. Public health experts, analysts, scientists, and those of us who work in the field find this a dangerous decision that will jeopardize national and global security and is scientifically reckless.
Are Your Quality Systems Inspection Ready?
An excellent and sustainable quality management system is the heartbeat of pharmaceutical safety and long-term compliance. This week in the Guardrail, we examine the shift from reactive audit preparation to a proactive culture of regulatory excellence.
Navigating Intense Drug Market Pressures
Today’s global drug market faces more pressure than ever before. Pharmaceutical companies deal with higher development costs, tougher regulations, stricter pricing, and more competition from generics and biosimilars. Meanwhile, patients, payers, and governments want quicker access to safe and effective treatments. These factors are changing how companies plan, develop, launch, and manage products over time.
To succeed, companies need to know what causes market pressure and how it shapes their decisions. They also have to adjust their strategies while keeping quality, safety, and compliance intact.
The Rise of Computer-Designed Antibodies and What It Means for Therapeutics
Recently, researchers have developed advanced computational tools to design antibodies in ways previously considered unattainable. This development could accelerate the discovery of new treatments and expand the range of treatable diseases.
Does Coffee Have an Impact on Cholesterol
This article explores how coffee affects cholesterol levels, how different brewing methods change that effect, and what current research suggests is the healthiest way to brew coffee.